Case reportPublished 22 Sep 2023
Fatal Dermatological Squeal Following Depot Medroxyprogesterone Acetate (DMPA) Administration: A Catastrophic Hypersensitivity Case Report
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The use of depot progesterone as a contraceptive every three months by a considerable number of women has raised concerns regarding the potential for hormones and chemicals to trigger fatal immune responses resulting in skin reactions. The focus of our case report is a 25-year-old woman who suffered a fatal dermatological condition after using this contraceptive. It is noteworthy that this specific condition has not been documented in medical literature before.
Subjects
DermatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Dermatology Research Journal
- SubjectDermatology
- BylineArticles whose byline prints “Aisha Siddiqui”
- BylineArticles whose byline prints “Farina Fatima Siddiqui”
- BylineArticles whose byline prints “Muhmmad Hamza Gul”
- BylineArticles whose byline prints “Yugam Rajeshkumar Oza”
- BylineArticles whose byline prints “Miruthu Varshini Jayaprakash”
